triazoles has been researched along with Gastrointestinal Stromal Neoplasm in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anjum, R; Banks, E; Barry, E; Bhavsar, D; Brown, C; Grondine, M; Guichard, SM; Jones, RDO; Kettle, JG; Pilla Reddy, V; Shao, W; Smith, A | 1 |
| Antonescu, CR; Balachandran, VP; Bowler, TG; Cross, JR; DeMatteo, RP; Liu, M; Loo, JK; Medina, BD; Moral, AJ; Param, NJ; Rossi, F; Vitiello, GA; Zeng, S; Zhang, JQ; Zhao, JN | 1 |
| Anjum, R; Barry, E; Bhavsar, D; Boyd, S; Brown, C; Campbell, A; Goldberg, K; Grondine, M; Guichard, S; Hardy, CJ; Hunt, T; Jones, RDO; Kettle, JG; Li, X; Moleva, O; Ogg, D; Overman, RC; Packer, MJ; Pearson, S; Schimpl, M; Shao, W; Smith, A; Smith, JM; Stead, D; Stokes, S; Tucker, M; Ye, Y | 1 |
| Andersen, JL; Armstrong, SA; Bradner, JE; Chipashvili, O; Demetri, GD; Hagan, T; Hemming, ML; Lawlor, MA; Raut, CP; Scott, TG; Sicinska, E | 1 |
| Bienkiewicz, A; Cialkowska-Rysz, A; Gora, E; Gottwald, L; Jesionek-Kupnicka, D; Korczynski, J; Morawiec, Z; Piekarski, JH; Sowa, P | 1 |
| Ballman, KV; Bot, B; Buckner, JC; DeMatteo, RP; Hillman, SL; Mandrekar, SJ; Nelson, H; Perez, EA; Sargent, DJ | 1 |
6 other study(ies) available for triazoles and Gastrointestinal Stromal Neoplasm
| Article | Year |
|---|---|
The Pharmacokinetic-Pharmacodynamic (PKPD) Relationships of AZD3229, a Novel and Selective Inhibitor of KIT, in a Range of Mouse Xenograft Models of GIST.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Gastrointestinal Stromal Tumors; Humans; Mice; Models, Biological; Mutation; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Quinazolines; Receptor, Platelet-Derived Growth Factor alpha; Triazoles; Xenograft Model Antitumor Assays | 2020 |
Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Hydrazones; Imatinib Mesylate; Metabolic Networks and Pathways; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mitochondria; Protein Kinase Inhibitors; Treatment Outcome; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors.
Topics: Drug Discovery; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Models, Molecular; Mutant Proteins; Mutation; Protein Conformation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Quinazolines; Tissue Distribution; Triazoles; Tumor Cells, Cultured | 2018 |
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition.
Topics: Animals; Apoptosis; Azepines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression; HEK293 Cells; Humans; Imatinib Mesylate; Mice; Mice, Nude; Protein Domains; Protein Kinase Inhibitors; Proteins; Proto-Oncogene Proteins c-kit; Triazoles; Xenograft Model Antitumor Assays | 2019 |
Primary uterine rhabdomyosarcoma in a patient with a history of breast cancer and gastrointestinal stromal tumor.
Topics: Aged; Anastrozole; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Gastrointestinal Stromal Tumors; Humans; Neoplasms, Second Primary; Nitriles; Rhabdomyosarcoma, Embryonal; Stomach; Triazoles; Uterine Neoplasms; Uterus | 2008 |
Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Benzamides; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lung Neoplasms; Male; Middle Aged; Piperazines; Placebos; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Triazoles; Young Adult | 2010 |